These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 10555148)

  • 1. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
    Lee JO; Yang H; Georgescu MM; Di Cristofano A; Maehama T; Shi Y; Dixon JE; Pandolfi P; Pavletich NP
    Cell; 1999 Oct; 99(3):323-34. PubMed ID: 10555148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.
    Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H
    Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
    Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
    J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
    Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
    Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
    Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
    Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species.
    Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.
    Georgescu MM; Kirsch KH; Akagi T; Shishido T; Hanafusa H
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10182-7. PubMed ID: 10468583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.
    Wu Y; Dowbenko D; Spencer S; Laura R; Lee J; Gu Q; Lasky LA
    J Biol Chem; 2000 Jul; 275(28):21477-85. PubMed ID: 10748157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN: The down side of PI 3-kinase signalling.
    Leslie NR; Downes CP
    Cell Signal; 2002 Apr; 14(4):285-95. PubMed ID: 11858936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
    Wishart MJ; Dixon JE
    Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
    Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate.
    Iwasaki H; Murata Y; Kim Y; Hossain MI; Worby CA; Dixon JE; McCormack T; Sasaki T; Okamura Y
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7970-5. PubMed ID: 18524949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PTEN-like phosphatase with a novel substrate specificity.
    Pagliarini DJ; Worby CA; Dixon JE
    J Biol Chem; 2004 Sep; 279(37):38590-6. PubMed ID: 15247229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity.
    Meuillet EJ; Mahadevan D; Berggren M; Coon A; Powis G
    Arch Biochem Biophys; 2004 Sep; 429(2):123-33. PubMed ID: 15313215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
    Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
    Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
    Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
    Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural assets of a tumor suppressor.
    Tonks NK; Myers MP
    Science; 1999 Dec; 286(5447):2096-7. PubMed ID: 10617421
    [No Abstract]   [Full Text] [Related]  

  • 19. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench.
    Wishart MJ; Taylor GS; Slama JT; Dixon JE
    Curr Opin Cell Biol; 2001 Apr; 13(2):172-81. PubMed ID: 11248551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of the Drosophila PTEN gene.
    Smith A; Smith A; Alrubaie S; Coehlo C; Leevers SJ; Ashworth A
    Biochim Biophys Acta; 1999 Oct; 1447(2-3):313-7. PubMed ID: 10542333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.